Our studies reveal that CHRNA7, a nicotine-enhanced receptor, confers high oncogenic potential by inducing CIC properties and serves as a predictor of poor prognostic in ESCC. The gene discussed is CHRNA7; the disease is esophageal squamous cell carcinoma.